Ischemic stroke
Conditions
Interventions
Experimental group:Routine ischemic stroke treatment, and An'gong Niuhuang Pill 3 g/time, nasal feeding or oral, once a day for 7 days
Sponsors
The First People's Hospital of Yuhang District, Hangzhou
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Aged over 18 years; 2. Acute severe ischemic stroke (NIHSS score > 15); 3. Within 24 hours of onset; 4. The diagnosis of cerebral infarction was in line with the standards of Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic stroke 2018; 5. The patient or the patient's agent signs the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with acute cerebral infarction receiving thrombolysis or surgery; 2. Patients with end-stage status at admission (GCS score < 5 or mydriasis fixed); 3. History of intracranial hemorrhage, intracranial space occupying, brain trauma or other brain diseases; 4. Patients with severe liver insufficiency (CTP grade B or above) and severe renal insufficiency (Ccr < 30 ml/min); 5. Patients with primary diseases and malignant tumors of hematopoietic system and immune system; 6. Patients who refused or withdrew from the study due to various reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 28 day mortality; | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement rate of early consciousness;Blood mercury concentration;Blood arsenic concentration;Urinary mercury concentration;Urinary arsenic concentration; | — |
Countries
China
Contacts
Public ContactWu Yunlong
The First People's Hospital of Yuhang District, Hangzhou
Outcome results
None listed